OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 8

OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace: 

Cyalume Technologies Holdings, Inc. (OTCQB: CYLU) – Cyalume Technologies is the world leader in chemiluminescent (chemical-light) technology, producing different variations of chemical-light products in all light wavelengths for the ammunition, military and public safety markets.  The products provide dependable light solutions for training and battlefield operations, safety and emergency demands and non-toxic ammunition alternatives.  Cyalume is the exclusive supplier to the U.S. and NATO-country militaries for all of their chemical-light needs and operates manufacturing facilities in the U.S. and France. 

MamaMancini's Holdings, Inc. (OTCQB: MMMB) – MamaMancini's is a marketer and distributor of a line of all-natural beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, pork meatballs with sauce, and other similar Italian products.

NaturalShrimp Incorporated (OTCQB: SHMP) – NaturalShrimp is a global shrimp farming company that is developing a technology to produce fresh, gourmet-grade shrimp reliably and economically in an indoor, re-circulating, saltwater facility.

The company’s eco-friendly, bio-secure design does not rely on ocean water.  It recreates the natural ocean environment allowing for high-density production which can be replicated anywhere in the world.

Proteo, Inc. (OTCQB: PTEO) – Proteo with its wholly owned subsidiary Proteo Biotech AG, a German corporation, is a clinical stage drug development company focused on the development of anti-inflammatory treatments for rare diseases with significant unmet needs.

Proteo's lead product Elafin is a copy of a naturally occurring human anti-inflammatory protein and promises an excellent therapeutic risk-benefit profile.  It is a potent inactivator of tissue destroying neutrophil elastase and proteinase-3, and was well tolerated in three randomized, double-blinded, placebo-controlled clinical studies.  Elafin’s ability to block tissue destroying proteases makes it a promising drug candidate for the prevention and treatment of tissue damage occurring in the course of major surgery, pulmonary diseases and severe reperfusion injury in organ transplantation.

Elafin is under clinical development for prophylactic treatment of acute postoperative complications, with focus on the prevention of postoperative inflammatory complications in the surgical therapy of esophageal cancer.  It’s potential for the treatment of pulmonary arterial hypertension and lung diseases is currently evaluated in preclinical models.

Elafin has obtained orphan drug designations for the treatment of complications of esophageal cancer surgery as well as for the treatment of pulmonary arterial hypertension in the United States and the European Union.

Proteo intends to establish international strategic partnerships for the development, manufacturing and marketing of Elafin. 

Searchlight Minerals Corp. (OTCQB: SRCH) – Searchlight Minerals is a dynamic mineral exploration company focused on the acquisition and development of projects in the southwestern United States.

 Xtra-Gold Resources Corp. (OTCQB: XTGRF) – Xtra-Gold Resources is a resource company with a lucrative placer gold mining opportunity and active lode gold exploration program in Ghana, West Africa.  While working towards gold production, the company is continuing to investigate gold exploration targets in a highly prospective gold belt analogous to the Ashanti Gold Belt (100 million ounces discovered to date). 

U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com. 

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to inform investors of opportunities and risks: the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and the OTC Pink® Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com. 

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. 

Subscribe to the OTC Markets RSS Feed 

Media Contact:

Saskia Sidenfaden
OTC Markets Group
+1 (212) 896-4428
saskia@otcmarkets.com